Navigation Links
BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research
Date:6/1/2009

Special Order BD LSRFortessa(TM) Benchtop Flow Cytometry System Supports up to Five Lasers and 18 Colors Simultaneously

SAN JOSE, Calif., June 1 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the launch of the new special order BD LSRFortessa(TM) cell analyzer, a powerful compact system that provides life science researchers with the ability to conduct complex multicolor flow cytometry experiments.

"Our special order research products program combines the knowledge gained from decades of working closely with leading researchers and excelling in manufacturing," said Jay Glasscock, President, Cell Analysis, BD Biosciences. "It allows us to work closely with customers to configure a BD LSRFortessa system that meets their exact specifications."

The BD LSRFortessa system offers power and flexibility in a benchtop footprint that is significantly smaller than the industry leading BD(TM) LSR II cell analyzer. It is the only compact cell analyzer that supports up to five lasers. Researchers can choose from 30 positions for detectors and 11 laser wavelengths and multiple power options to detect up to 18 colors simultaneously. Working with BD Biosciences' flow cytometry experts, laboratories can configure a system that meets their precise assay requirements.

"Space is at a premium in most research settings, leading many labs to compromise system power and performance because of space limitations," said Glasscock. "The new BD LSRFortessa system eliminates the need for that sacrifice by addressing researchers' growing analytical needs and helping to maximize lab space utilization at the same time."

The BD LSRFortessa system is the newest addition to the proven line of BD(TM) LSR cell analyzers. The original BD LSR II system supports up to seven lasers and has been the preferred tool of life science researchers worldwide working in core, academic, pharmaceutical and biotechnology laboratories.

For more information about the BD LSRFortessa cell analyzer, as well as the complete BD LSR product line, please visit: http://www.bdbiosciences.com/lsr.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
4. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
5. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
6. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
7. Anaptys Biosciences Raises Over $33 Million in Series B Financing
8. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
9. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
10. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
11. Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process Analytics is ... plant water and steam. , Chlorides and sulfates cause pitting and stress corrosion ... maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels has therefore ...
(Date:3/28/2017)... Los Angeles, CA (PRWEB) , ... March 28, ... ... Pediatrics credential, which will be offered by the American Association of Integrative Medicine ... Saturday presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. ...
(Date:3/28/2017)... ... 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader ... women’s hair loss. Although hair transplant procedures can be seen as more of a ... can be two reasons a woman may see her hair thinning. , “We are ...
(Date:3/28/2017)... ... ... are probably not the first ingredients that come to mind when thinking about healthy food. ... can actually improve health outcomes. And the good news is they may be hiding in ... peer-reviewed paper led by Maria Marco, Ph.D. , University of California, Davis and ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Drs. Justin Kolnick, ... Week by teaching their patients about the key role this treatment plays in protecting ... an experienced endodontist. To better serve those who need a root canal in White ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CAMBRIDGE, Mass. , March 28, 2017  Akcea Therapeutics, ... three additions to the company,s board of directors: ... Bessemer Venture Partners. Mr. Gabrieli will serve as chairman of ... Hochberg , former chief commercial officer of Forest Laboratories. ... of Global Biolink Partners. "We are ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, ... device company, is pleased to announce that the ... investment of Panther Orthopedics, Inc., a ... dynamic fixation solutions for orthopedic extremity applications.  ... to expand rapidly, primarily due to procedure volume ...
Breaking Medicine Technology: